Sept 15, 2026 Seoyoung Kang edition.cnn.com Moderna’s stock price recently rose after the company announced successful results from a Phase 3 clinical trial of a personalized mRNA cancer vaccine developed with Merck. This news has increased expectations that Moderna could enter the cancer treatment market. The outcome is especially important because it is the first positive Phase 3 result for a personalized mRNA-based cancer treatment. Moderna and Merck are now working toward

Jan 25, 2025 Gyeonghyun Cho dukeghic.org When Covid19 broke out in 2020, most people visited the hospital to have a shot of Covid19 vaccine to prevent the spread of the virus. However, vaccine exemption rates for school-required childhood immunization have increased across much of the United States after Covid pandemic, mainly due to nonmedical exemptions based on personal religious beliefs. Most experts assume that misinformation, political debates, and vaccine hesitancy con